Laurence Barrier

1.7k total citations
37 papers, 1.4k citations indexed

About

Laurence Barrier is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Laurence Barrier has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 6 papers in Neurology. Recurrent topics in Laurence Barrier's work include Neuroscience and Neuropharmacology Research (12 papers), Sphingolipid Metabolism and Signaling (6 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Laurence Barrier is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Sphingolipid Metabolism and Signaling (6 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Laurence Barrier collaborates with scholars based in France, Canada and Belize. Laurence Barrier's co-authors include Bernard Fauconneau, François Huguet, Guylène Page, Alain Décendit, Pierre Waffo‐Téguo, Jean‐Michel Mérillon, Alain Piriou, Sabrina Ingrand, Jacques Hugon and J.‐M. VIERFOND and has published in prestigious journals such as Hepatology, Brain Research and FEBS Letters.

In The Last Decade

Laurence Barrier

37 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurence Barrier France 17 529 290 243 194 192 37 1.4k
Maria D’Erme Italy 22 715 1.4× 312 1.1× 81 0.3× 164 0.8× 141 0.7× 72 1.7k
Geetha Ghai United States 26 851 1.6× 219 0.8× 270 1.1× 76 0.4× 168 0.9× 36 2.1k
François Huguet France 15 352 0.7× 152 0.5× 74 0.3× 254 1.3× 177 0.9× 33 1.0k
Emile Andriambeloson France 18 390 0.7× 351 1.2× 124 0.5× 67 0.3× 143 0.7× 36 1.5k
Jung-Hee Jang South Korea 23 978 1.8× 465 1.6× 80 0.3× 214 1.1× 179 0.9× 51 2.0k
Mao Lin China 23 542 1.0× 155 0.5× 167 0.7× 236 1.2× 145 0.8× 52 1.3k
Francisco J. Alcaı́n Spain 23 904 1.7× 408 1.4× 102 0.4× 410 2.1× 74 0.4× 53 1.8k
Jiyin Zhou China 23 470 0.9× 315 1.1× 78 0.3× 81 0.4× 146 0.8× 44 1.9k
Jin‐Tae Hong South Korea 30 1.0k 1.9× 202 0.7× 249 1.0× 63 0.3× 106 0.6× 81 2.1k
Ilaria Luccarini Italy 19 436 0.8× 565 1.9× 212 0.9× 44 0.2× 204 1.1× 20 1.4k

Countries citing papers authored by Laurence Barrier

Since Specialization
Citations

This map shows the geographic impact of Laurence Barrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Barrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Barrier more than expected).

Fields of papers citing papers by Laurence Barrier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Barrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Barrier. The network helps show where Laurence Barrier may publish in the future.

Co-authorship network of co-authors of Laurence Barrier

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence Barrier. A scholar is included among the top collaborators of Laurence Barrier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence Barrier. Laurence Barrier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Noël, Anastasia, Sabrina Ingrand, & Laurence Barrier. (2017). Ganglioside and related-sphingolipid profiles are altered in a cellular model of Alzheimer's disease. Biochimie. 137. 158–164. 8 indexed citations
2.
Dupuis, Antoine, Laurence Barrier, Pascal Carato, et al.. (2017). Validation of a probe for assessing deconjugation of glucuronide and sulfate phase II metabolites assayed through LC–MS/MS in biological matrices. Journal of Chromatography B. 1061-1062. 72–78. 10 indexed citations
3.
Noël, Anastasia, Sabrina Ingrand, & Laurence Barrier. (2016). Anti-amyloidogenic effects of glycosphingolipid synthesis inhibitors occur independently of ganglioside alterations. Molecular and Cellular Neuroscience. 75. 63–70. 9 indexed citations
4.
Noël, Anastasia, Sabrina Ingrand, & Laurence Barrier. (2015). Inhibition of GSK3β by pharmacological modulation of sphingolipid metabolism occurs independently of ganglioside disturbance in a cellular model of Alzheimer's disease. Experimental Neurology. 271. 308–318. 4 indexed citations
5.
Barrier, Laurence, Sabrina Ingrand, Bernard Fauconneau, & Guylène Page. (2008). Gender-dependent accumulation of ceramides in the cerebral cortex of the APPSL/PS1Ki mouse model of Alzheimer’s disease. Neurobiology of Aging. 31(11). 1843–1853. 31 indexed citations
6.
Pain, Stéphanie, Laurence Barrier, Julie Deguil, et al.. (2007). A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats. Toxicology. 243(1-2). 124–137. 8 indexed citations
7.
Ingrand, Sabrina, Laurence Barrier, Claire Lafay‐Chebassier, et al.. (2007). The oxindole/imidazole derivative C16 reduces in vivo brain PKR activation. FEBS Letters. 581(23). 4473–4478. 69 indexed citations
8.
Bilan, Agnès Rioux, Sabrina Ingrand, Stéphanie Pain, et al.. (2007). Regulation of initiation factors controlling protein synthesis on cultured astrocytes in lactic acid‐induced stress. European Journal of Neuroscience. 26(3). 689–700. 8 indexed citations
9.
Bilan, Agnès Rioux, Laurence Barrier, Raymond Pontcharraud, et al.. (2006). Fluoro-Jade® B staining as useful tool to identify activated microglia and astrocytes in a mouse transgenic model of Alzheimer's disease. Brain Research. 1128(1). 40–49. 80 indexed citations
11.
13.
Barrier, Laurence, Guylène Page, Stéphanie Pain, Alain Piriou, & Jacques Portoukalian. (2002). Sulfatide and GM1 ganglioside modulate the high-affinity dopamine uptake in rat striatal synaptosomes: evidence for the involvement of their ionic charges. Neurochemistry International. 42(4). 305–313. 13 indexed citations
14.
Dubuisson, L, Alexis Desmoulière, Boris Decourt, et al.. (2002). Inhibition of rat liver fibrogenesis through noradrenergic antagonism. Hepatology. 35(2). 325–331. 66 indexed citations
15.
Page, Guylène, Sylvie Chalon, Laurence Barrier, Alain Piriou, & François Huguet. (1998). Characterization of both dopamine uptake systems in rat striatal slices by specific pharmacological tools. Neurochemistry International. 33(5). 459–466. 6 indexed citations
16.
Page, Guylène, et al.. (1998). Possible Relationship between Changes in [3H]DA Uptake and Autoxidation in Rat Striatal Slices. Experimental Neurology. 152(1). 88–94. 13 indexed citations
18.
Barrier, Laurence, et al.. (1997). Alterations in the ganglioside composition of rat cortical brain slices during experimental lactic acidosis: implication of an enzymatic process independent of the oxidative stress. Biochimica et Biophysica Acta (BBA) - General Subjects. 1336(1). 15–22. 9 indexed citations
19.
Tallineau, C., et al.. (1995). Lack of correlation between TBARS production and PUFA degradation during incubation of membrane erythrocytes in an OH⋅ (Fe2+/H2O2) generator system. Biological Trace Element Research. 47(1-3). 3–7. 6 indexed citations
20.
Barrier, Laurence, et al.. (1980). An in vivo model for testing somatostatin suppression of growth hormone release in sheep. Journal of Endocrinological Investigation. 3(3). 237–241. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026